Skip to content
Search

Latest Stories

GOPO® for joint health

pharmacy.biz Staff
By pharmacy.biz StaffMay 22, 2020
pharmacy.biz Staff
See Full Bio

Pharmacists have a key role when it comes to advising customers on options to support their long-term joint health, rather than simply recommending a ‘quick fix’.

GOPO® Joint Health provides a scientifically documented rosehip powder that is made using a specialist process to ensure that the powder retains high levels of the galactolipid GOPO®. Rosehip may play a valuable role in the care of joints and joint tissues. The galactolipid GOPO® has been studied in over 20 scientific trials.

GOPO Joint Health is also rich in Vitamin C which is essential for normal collagen formation, needed by the body for healthy bones and cartilage.

High levels of the galactolipid GOPO® are found only in GOPO® Joint Health.

For more information visit the GOPO® Website: www.gopo.co.uk

Or call GR Lanes Health: 01452 524012

Related News

Regulators warn pharmacies over advertising of weight management medicines

Do not promote weight management medicines to the public: Regulators warn pharmacies

Community pharmacies should stop offering services for free
News

“Stop doing things for free”- Pharmacy leaders urge contractors

GPhC cautions pharmacies over supply of Lemon Bottle, alternative therapies

Pharmacies cautioned over supply of 'Lemon Bottle' and alternative therapies

Pollen bomb to hit UK: Pharmacist warns of these unusual hay fever symptoms

Hay fever: Pharmacist explains 5 surprising symptoms as “pollen bomb” set to hit UK

More For You

ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine, survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less
Independent Prescribing: Government aims to complete pathfinder programme evaluation by autumn 2025

Pharmacist prescribers at 210 ‘pathfinder’ sites were allowed to trial prescribing models within integrated primary care services.

Photo credit: gettyimages

Independent prescribing: Pathfinder programme evaluation to be completed by autumn, says Kinnock

Health minister Stephen Kinnock has revealed that the evaluation of the Community Pharmacy Independent Prescribing Pathfinder Programme could be completed by Autumn 2025.

Kinnock was responding to a question from James Naish, Labour MP for Rushcliffe, who asked what steps the minister was taking to ensure continued support for the Pathfinder Programme and independent prescribing to maximise direct prescribing capacity in England.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc